SCHEMBL6544049

SCHEMBL6544049

COC(=O)c1ccc(C2CSCN2C(=O)OC(C)(C)C)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 12/20 0.42
NR1H2 P55055 2/20 0.42
NR1H3 Q13133 2/20 0.42
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
HSD17B10 Q99714 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ATM Q13315 1/20 0.36
EED O75530 1/20 0.36
RBBP4 Q09028 1/20 0.36
SUZ12 Q15022 1/20 0.36
EZH2 Q15910 1/20 0.36
AEBP2 Q6ZN18 1/20 0.36
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RXRA P19793 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153880 0.81 PDE4B (0.44) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL30606456 0.81 PDE4B (0.42) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL5153357 0.81 PDE4B (0.44) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL5152868 0.81 PDE4B (0.42) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL5153277 0.81 PDE4B (0.42) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL27570444 0.80 NR1H2 (0.35) PDE4BNR1H2NR1H3HSD17B10NPSR1
SCHEMBL5153201 0.80 PDE4B (0.44) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL5150005 0.80 PDE4B (0.44) PDE4BNR1H2NR1H3PDE4APDE4C
SCHEMBL5150263 0.78 NR1H2 (0.46) PDE4BNR1H2NR1H3RXRA
SCHEMBL6542920 0.77 PDE4B (0.40) PDE4BNR1H2NR1H3PDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756378-B2 BENZYL -UREA, -THIOUREA, OR -GUANIDINE DERIVATIVES THAT INHIBIT THE BINDING OF LIGANDS TO ALPHA 4 BETA 1 INTEGRIN (VLA-4) PHARMACOPEIA DRUG DISCOVERY, INC. 2004-06-29 US disclosed